Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

VViking Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
V

Viking Therapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

SellBuy
DateNameTitleSharesValueTransactionSource
Aug 1, 2026Kelly-Gemmell Dorothy ElizabethDirector40,800Stock Option (Right to Buy)—Grant / award
Aug 1, 2026Kelly-Gemmell Dorothy ElizabethDirector6,333Common Stock, par value $0.00001 per share—Grant / award
Jul 29, 2026Mancini MariannaChief Operating Officer18,217Common Stock, par value $0.00001 per share—Sell
Jul 29, 2026ZANTE GREGChief Financial Officer21,217Common Stock, par value $0.00001 per share—Sell
Jul 29, 2026Lian BrianPresident & CEO148,517Common Stock, par value $0.00001 per share—Sell
Jul 28, 2026Mancini MariannaChief Operating Officer31,667Common Stock, par value $0.00001 per share—Grant / award
Jul 28, 2026ZANTE GREGChief Financial Officer31,667Common Stock, par value $0.00001 per share—Grant / award
Jul 28, 2026Lian BrianPresident & CEO221,667Common Stock, par value $0.00001 per share—Grant / award
Jun 1, 2026Chen Hubert CChief Medical Officer190,000Stock Option (Right to Buy)—Grant / award
Mar 10, 2026Aubuchon Neil WilliamChief Commercial Officer4,475Common Stock, par value $0.00001 per share—Buy
…
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions